日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antihypertensive treatment guided by genetics: PEARL-HT, the randomized proof-of-concept trial comparing rostafuroxin with losartan

基于遗传学的抗高血压治疗:PEARL-HT,一项比较罗司他呋喃西林与氯沙坦的随机概念验证试验

Citterio, Lorena; Bianchi, Giuseppe; Scioli, Giuseppe A; Glorioso, Nicola; Bigazzi, Roberto; Cusi, Daniele; Staessen, Jan A; Cavuto, Silvio; Ferrandi, Mara; Lanzani, Chiara; Li, Xiaoyi; Lau, Lit-Fui; Chiang, Chern-En; Wang, Tzung-Dau; Wang, Kang-Ling; Ferrari, Patrizia; Manunta, Paolo

In Vitro and In Vivo Anticancer Activity of Gimatecan against Hepatocellular Carcinoma

吉马替康体外和体内抗肝细胞癌活性

Zhao, Youna; Lau, Lit-Fui; Dai, Xiangrong; Li, Benjamin

A novel snake venom-derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury.

一种新型的蛇毒衍生的 GPIb 拮抗剂安非巴肽可保护小鼠免受急性实验性缺血性中风和再灌注损伤

Li Ting-Ting, Fan Man-Li, Hou Shi-Xiang, Li Xiao-Yi, Barry Devin M, Jin Hui, Luo Sheng-Yong, Kong Feng, Lau Lit-Fui, Dai Xiang-Rong, Zhang Guo-Hui, Zhou Lan-Lan